Why I’d dump a 10-bagger for this small-cap growth stock

Looking for growth at a reasonable price? This small-cap might be just the ticket.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

While investors should never dwell on their regrets, one that must top many lists is failing to buy shares in tonic water specialist Fevertree Drinks (LSE: FEVR) towards the end of 2014. If you’d had the skill (or good fortune) to do this, the value of your holding would have increased tenfold over the last two-and-a-half years.

Can the shares continue to rise? Sure, assuming the company can provide evidence that it has managed to build on last year’s excellent performance when it delivers half-year figures on 24 July. 

The only problem with this is the fact that 2016 was such a superb year for Fevertree. April’s full-year report highlighted a 73% increase in revenue (to £102m) and 97% rise in adjusted EBITDA (to almost £36m). Beating these figures in 2017 is no easy task and any sign that momentum is slowing could see many holders jettison the stock from their portfolios.

To further muddy the investment case, Fevertree’s popularity as a growth stock par excellence following its tendency to beat earnings estimates has left it trading on a gravity-defying 61 times forward earnings.

And given that anything over, say, two is indicative of a stock trading at a fairly high price relative to the predicted growth of the underlying company, Fevertree’s price-to earnings growth (PEG) ratio of over 5.2 also implies that the stock looks horribly expensive.

A more appealing option

If, like me, you’re put off by the possibility of Fevertree’s crown slipping, an alternative stock with decent growth credentials might be drinks wholesaler, distributor, and retailer, Conviviality (LSE: CVR). Today’s full-year results were certainly encouraging.

Thanks to a series of acquisitions (which all appear to have been integrated ahead of schedule), the £550m cap business grew revenue by 85% to £1.56bn in the year to the end of April, with adjusted pre-tax profits rocketing 111% to just under £46m.  

Broken down, the company reflected that all areas of the business had performed strongly.

A 6.4% increase in revenue (to just over £1bn) was seen at Conviviality Direct (its wholesale unit) with a total of 235 customers being added over the course of the year. 

Trading under its Wine Rack and Bargain Booze brands, revenue at its retail arm rose 6.1% to £378m. A total of 39 new franchisees joined the company last year, bringing the total number to 352 (and over 700 stores). 

In Conviviality Trading — which serves festivals and outdoor events — sales hit £146m — a rise of 1%.

Given this more-than-adequate performance, you might expect the shares to be trading at a fairly high valuation. This simply isn’t the case. Right now, you can pick up its shares at just 13 times forecast earnings. 

Remember Fevertree’s sky high PEG? Conviviality’s is 1.8 for 2017. That means investors will be getting access to earnings growth an awful lot more cheaply at the latter.

In addition to its reasonable valuation and growth potential, it’s also worth highlighting that the Crewe-based company’s shares come with a forecast 4.3% yield for the new financial year, nicely covered by profits. Given that levels of free cashflow at Conviviality climbed 349% to £51m by the end of the last financial year (which permitted the company to raise the full-year dividend by no less than 33%), I wouldn’t be surprised if the stock also becomes a core holding for many income investors in the years ahead.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Paul Summers has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Passive income text with pin graph chart on business table
Investing Articles

Does a 9.3% yield and a growing dividend make Legal & General shares a passive income no-brainer?

Legal & General shares have been a bad investment over the last five years. But could it be a huge…

Read more »

Charticle

2 brilliant (but very different) shares I want to buy if they get cheaper in 2025!

This contrasting pair of businesses has caught our writer's eye. But he is not ready to buy the shares at…

Read more »

Investing Articles

3 steps to start buying shares with a spare £250

Christopher Ruane explains three simple but important principles he thinks people should consider when they start buying shares, even with…

Read more »

Light trails from traffic moving down The Mound in central Edinburgh, Scotland during December
Investing Articles

FTSE 100 shares: bargain hunting to get richer!

After hitting a new high this year, might the FSTE 100 still offer bargain shares to buy? Our writer thinks…

Read more »

Investing Articles

How to try and turn a £50K SIPP into a £250K retirement fund

Christopher Ruane explains how a long-term approach and careful share selection could potentially help an investor quintuple the value of…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

My £3 a day passive income plan for 2025

Christopher Ruane walks through his plan for next year and beyond of squirreling away and investing a few pounds a…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

Can the FTSE 250’s Raspberry Pi boost my portfolio over the next decade?

This British technology stock in the FTSE 250 has exploded onto the London stock market and right now its future…

Read more »

Investing Articles

Does acquiring Direct Line make Aviva shares a buy?

A big acquisition should give Aviva greater scale and profitability, increasing the value of its shares. But is it an…

Read more »